Pay in 4 interest-free payments of $7.08 Learn more
Ships within 48 hours · Estimated delivery Nov 4 - Nov 9
Holmes CJ, Racette SB
Glucagon-like peptide-1 (GLP-1) receptor agonists (GLP-1RAs) are approved for the treatment of type 2 diabetes (T2D) and obesity, and their safety and tolerability profiles are well established in these populations
6 Looking ahead Theres promising emerging data to suggest potential benefits of using GLP-1s for other health conditions
However, they have different formulations and methods of administration
Research shows that only about 1 in 10 people with a BMI of 25 or higher will lose 5 percent of their body weight and keep it off with lifestyle changes alone
US$ 26.99
US$ 28.90
US$ 23.36
